AbCellera Corp (ABCL) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
Diversifying hundreds of partnerships with pharma behemoths minimizes the financial risks for AbCellera Biologics (ABCL) in the event of individual test failures. The historical EV/EBITDA value visualizes the link between asset value and profit, while the 0.00 metric reflects current dynamics. The environmental strategy relies on laboratory energy efficiency, and technological leadership in AI-driven antibody discovery exponentially accelerates R&D processes.
AbCellera Biologics Inc. - analytical breakdowns and key metrics (ABCL)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
ABCL - Net Income|Projected Future Earnings AbCellera Biologics|ABCL - Market Cap to Earnings|Future Price to Earnings AbCellera Biologics|ABCL - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AbCellera Bio|ABCL - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) AbCellera|ABCL - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months abcellera.com|ABCL - Earnings per share increase in current year|Earnings growth forecast for next year AbCellera Biologics
Initial company analysis:AbCellera Bio ABCL
For AbCellera Biologics (ABCL), which leverages AI and partnerships with pharma behemoths, the EV/EBITDA multiple reflects the operational cash flow's ability to cover the total enterprise value, including net debt. Analyzing this metric allows for a comparison of market capitalization and liabilities against earnings before interest, taxes, depreciation, and amortization, determining the investment attractiveness of the capital through the lens of resilience to macroeconomic risks.
Competitors of AbCellera Biologics
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies (ADPT)|celldex.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Company Value to EBITDA|Vera Pharma - EV/EBITDA Multiple|DNTH - EV/EBITDA Multiple|PHVS: EV/EBITDA Multiple|TRML (tourmalinebio.com) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|PGEN (Precigen) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Pharming Group NV (PHAR)|EV/EBITDA Multiple NKTR|UPB - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Zenas Biopharma Inc ZBIO|immunome.com - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|GOSS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|KALV: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SEPN: EV/EBITDA Multiple|Company Value to EBITDA Pieris Corp (PVLA)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Savara Inc.|RIGL: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ANAB|EV/EBITDA Multiple Astria Therapeutics Inc (ATXS)|enGene Bio - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation RAPT|Aerovate - EV/EBITDA Multiple|ACRS: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|KYTX: EV/EBITDA Multiple|TLSA - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cabaletta Bio, Inc|Company Value to EBITDA Ventyx Biosciences, Inc VTYX|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Theratechnologies Inc. (THTX)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AVTX (avalotx.com)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Eledon Pharmaceuticals, Inc. ELDN|Agenus, Inc. (AGEN) - Company Value to EBITDA|Climb Bio, Inc. - EV/EBITDA Multiple|Enterprise Value to EBITDA Multiple zurabio.com (ZURA)|ATYR: EV/EBITDA Multiple|ADAG - Total Company Value to Operating Income Before Depreciation Ratio|IMA (ImageneBio) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Shattuck Therapeutics (STTK)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Equillium, Inc. (EQ)|Total Company Value to Operating Income Before Depreciation Ratio connectbiopharm.com|EV/EBITDA Multiple IMUX (Immunic)|EV/EBITDA Multiple Atara Biotherapeutics, Inc. ATRA|InflaRx GmbH - EV/EBITDA Multiple|XFOR: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ACET: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Celularity|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INmune Bio, Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization BRNS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Kezar Life Sciences, Inc. (KZR)|SABS: Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple AKTX (Akari Therapeutics plc)|Business Value to Operating Income Before Depreciation ENLV|Q32 Bio Corp - EV/EBITDA Multiple|GOVX - EV/EBITDA Multiple|Edesa Biotech (EDSA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|iBio Inc - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Carisma Therapeutics Inc|Enterprise Value to EBITDA Ratio XTL Bio (XTLB)|EV/EBITDA Multiple BOLT|EV/EBITDA Multiple hcwbiologics.com (HCWB)|Aptevo Therapeutics Inc. - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation AIM|Aditxt Corp - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio GRI Bio Corporation GRI|XORTX Therapeutics Inc. (XRTX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio reshapelifesciences.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Revelation Biosciences, Inc.|Enterprise Value to EBITDA Ratio Indaptus Therapeutics Inc (INDP)|Enterprise Value to EBITDA Ratio SCNI (Scinai)|EV/EBITDA Multiple calcimedica.com (CALI)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Affimed N.V. AFMD|ALLK: Enterprise Value to Operating Income Before Depreciation|HOOKIPA - EV/EBITDA Multiple|Company Value to EBITDA IGM Biosciences, Inc.|ITOS: EV/EBITDA Multiple|Ocean Biomedical Corp (OCEA) - EV/EBITDA Multiple|TCBP (TC Biopharm) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization THRD
